Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 17, 2017 10:29 ET | Source: National Lipid Association

FOURIER Trial Reveals Significant Reduction in Cardiovascular Risk

WASHINGTON, DC--(Marketwired - March 17, 2017) - The FOURIER trial lead investigators announced today that the PCSK9 inhibitor evolocumab significantly reduced the risk of cardiovascular events by...